2021 Safety and Availability Communications
This webpage was developed to provide the public with important information about the safety and availability of biological products.
March 2021
- FDA Requires a Warning about Guillain-Barré Syndrome (GBS) be Included in the Prescribing Information for Shingrix
March 24, 2021
February 2021
- COVID-19 Vaccine Safety Surveillance
February 9, 2021